Death in the fast lane: what's next for necroptosis?

FEBS Journal

Volumn , Issue , 2016, Pages 2616-2625

  Oberst, Andrew ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

apoptosis; caspase 8; MLKL; necroptosis; RIPK1; RIPK3

Indexed keywords

CASPASE 8; FLICE INHIBITORY PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN; MIXED LINEAGE KINASE; MIXED LINEAGE KINASE DOMAIN LIKE PROTEIN; PROTEIN KINASE; RECEPTOR INTERACTING PROTEIN KINASE 1; RECEPTOR INTERACTING PROTEIN KINASE 3; UNCLASSIFIED DRUG;

APOPTOSIS; CELL DESTRUCTION; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; IMMUNE RESPONSE; NECROPTOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; REVIEW;

EID: 84979010040     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/febs.13520     Document Type: Review

References (66)

1. Chan FK-M, Luz NF & Moriwaki K (2014) Programmed necrosis in the cross talk of cell death and inflammation. Annu Rev Immunol 33, 141210135520002.
2. Weinlich R & Green DR (2014) The two faces of receptor interacting protein kinase-1. Mol Cell 56, 469–480.
3. Silke J, Rickard JA & Gerlic M (2015) The diverse role of RIP kinases in necroptosis and inflammation. Nat Immunol 16, 689–697.
4. Linkermann A & Green DR (2014) Necroptosis. N Engl J Med 370, 455–465.
5. Degterev A, Huang Z, Boyce M, Li Y, Jagtap P, Mizushima N, Cuny GD, Mitchison TJ, Moskowitz MA & Yuan J (2005) Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol 1, 112–119.
6. Krysko DV, Garg AD, Kaczmarek A, Krysko O, Agostinis P & Vandenabeele P (2012) Immunogenic cell death and DAMPs in cancer therapy. Nat Rev Cancer 12, 860–875.
7. Kearney CJ, Cullen SP, Tynan GA, Henry CM, Clancy D, Lavelle EC & Martin SJ (2015) Necroptosis suppresses inflammation via termination of TNF- or LPS-induced cytokine and chemokine production. Cell Death Differ 22, 1313–1327.
8. Kaiser WJ & Offermann MK (2005) Apoptosis induced by the toll-like receptor adaptor TRIF is dependent on its receptor interacting protein homotypic interaction motif. J Immunol 174, 4942–4952.
9. Sun X, Yin J, Starovasnik MA, Fairbrother WJ & Dixit VM (2002) Identification of a novel homotypic interaction motif required for the phosphorylation of receptor-interacting protein (RIP) by RIP3. J Biol Chem 277, 9505–9511.
10. Kaiser WJ, Upton JW & Mocarski ES (2008) Receptor-interacting protein homotypic interaction motif-dependent control of NF-kappa B activation via the DNA-dependent activator of IFN regulatory factors. J Immunol 181, 6427–6434.
11. Sun L, Wang H, Wang Z, He S, Chen S, Liao D, Wang L, Yan J, Liu W, Lei X et al. (2012) Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase. Cell 148, 213–227.
12. Murphy JM, Czabotar PE, Hildebrand JM, Lucet IS, Zhang J-G, Alvarez-Diaz S, Lewis R, Lalaoui N, Metcalf D, Webb AI et al. (2013) The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism. Immunity 39, 443–453.
13. Wang H, Sun L, Su L, Rizo J, Liu L, Wang L-F, Wang F-S & Wang X (2014) Mixed lineage kinase domain-like protein MLKL causes necrotic membrane disruption upon phosphorylation by RIP3. Mol Cell 54, 133–146.
14. Dondelinger Y, Declercq W, Montessuit S, Roelandt R, Goncalves A, Bruggeman I, Hulpiau P, Weber K, Sehon CA, Marquis RW et al. (2014) MLKL compromises plasma membrane integrity by binding to phosphatidylinositol phosphates. Cell Rep 7, 971–981.
15. Cai Z, Jitkaew S, Zhao J, Chiang H-C, Choksi S, Liu J, Ward Y, Wu L-G & Liu Z-G (2013) Plasma membrane translocation of trimerized MLKL protein is required for TNF-induced necroptosis. Nat Cell Biol 16, 55–65.
16. Li J, McQuade T, Siemer AB, Napetschnig J, Moriwaki K, Hsiao Y-S, Damko E, Moquin D, Walz T, McDermott A et al. (2012) The RIP1/RIP3 necrosome forms a functional amyloid signaling complex required for programmed necrosis. Cell 150, 339–350.
17. Orozco S, Yatim N, Werner MR, Tran H, Gunja SY, Tait SW, Albert ML, Green DR & Oberst A (2014) RIPK1 both positively and negatively regulates RIPK3 oligomerization and necroptosis. Cell Death Differ 21, 1511–1521.
18. Wu X-N, Yang Z-H, Wang X-K, Zhang Y, Wan H, Song Y, Chen X, Shao J & Han J (2014) Distinct roles of RIP1-RIP3 hetero- and RIP3-RIP3 homo-interaction in mediating necroptosis. Cell Death Differ 21, 1709–1720.
19. Chen W, Zhou Z, Li L, Zhong CQ, Zheng X, Wu X, Zhang Y, Ma H, Huang D, Li W et al. (2013) Diverse sequence determinants control human and mouse receptor interacting protein 3 (RIP3) and mixed lineage kinase domain-Like (MLKL) interaction in necroptotic signaling. J Biol Chem 288, 16247–16261.
20. Tait SWG, Oberst A, Quarato G, Milasta S, Haller M, Wang R, Karvela M, Ichim G, Yatim N, Albert ML et al. (2013) Widespread mitochondrial depletion via mitophagy does not compromise necroptosis. Cell Rep 5, 878–885.
21. Kazama H, Ricci J-E, Herndon JM, Hoppe G, Green DR & Ferguson TA (2008) Induction of immunological tolerance by apoptotic cells requires caspase-dependent oxidation of high-mobility group box-1 protein. Immunity 29, 21–32.
22. Oberst A, Dillon CP, Weinlich R, McCormick LL, Fitzgerald P, Pop C, Hakem R, Salvesen GS & Green DR (2011) Catalytic activity of the caspase-8-FLIP(L) complex inhibits RIPK3-dependent necrosis. Nature 471, 363–367.
23. Kaiser WJ, Upton JW, Long AB, Livingston-Rosanoff D, Daley-Bauer LP, Hakem R, Caspary T & Mocarski ES (2011) RIP3 mediates the embryonic lethality of caspase-8-deficient mice. Nature 471, 368–372.
24. Feoktistova M, Geserick P, Kellert B, Dimitrova DP, Langlais C, Hupe M, Cain K, MacFarlane M, Häcker G & Leverkus M (2011) cIAPs block Ripoptosome formation, a RIP1/caspase-8 containing intracellular cell death complex differentially regulated by cFLIP isoforms. Mol Cell 43, 449–463.
25. Tenev T, Bianchi K, Darding M, Broemer M, Langlais C, Wallberg F, Zachariou A, Lopez J, MacFarlane M, Cain K et al. (2011) The ripoptosome, a signaling platform that assembles in response to genotoxic stress and loss of IAPs. Mol Cell 43, 432–448.
26. Moulin M, Anderton H, Voss AK, Thomas T, Wong WW-L, Bankovacki A, Feltham R, Chau D, Cook WD, Silke J et al. (2012) IAPs limit activation of RIP kinases by TNF receptor 1 during development. EMBO J 31, 1679–1691.
27. Yabal M, Müller N, Adler H, Knies N, Groß CJ, Damgaard RB, Kanegane H, Ringelhan M, Kaufmann T, Heikenwalder M et al. (2014) XIAP restricts TNF- and RIP3-dependent cell death and inflammasome activation. Cell Rep 7, 1796–1808.
28. Dillon CP, Weinlich R, Rodriguez DA, Cripps JG, Quarato G, Gurung P, Verbist KC, Brewer TL, Llambi F, Gong Y-N et al. (2014) RIPK1 blocks early postnatal lethality mediated by caspase-8 and RIPK3. Cell 157, 1189–1202.
29. Rickard JA, O'Donnell JA, Evans JM, Lalaoui N, Poh AR, Rogers T, Vince JE, Lawlor KE, Ninnis RL, Anderton H et al. (2014) RIPK1 regulates RIPK3-MLKL-driven systemic inflammation and emergency hematopoiesis. Cell 157, 1175–1188.
30. Kaiser WJ, Daley-Bauer LP, Thapa RJ, Mandal P, Berger SB, Huang C, Sundararajan A, Guo H, Roback L, Speck SH et al. (2014) RIP1 suppresses innate immune necrotic as well as apoptotic cell death during mammalian parturition. Proc Natl Acad Sci USA 111, 7753–7758.
31. Thapa RJ, Nogusa S, Chen P, Maki JL, Lerro A, Andrake M, Rall GF, Degterev A & Balachandran S (2013) Interferon-induced RIP1/RIP3-mediated necrosis requires PKR and is licensed by FADD and caspases. Proc Natl Acad Sci USA 110, E3109–18.
32. Berger SB, Kasparcova V, Hoffman S, Swift B, Dare L, Schaeffer M, Capriotti C, Cook M, Finger J, Hughes-Earle A et al. (2014) Cutting Edge: RIP1 kinase activity is dispensable for normal development but is a key regulator of inflammation in SHARPIN-deficient mice. J Immunol 192, 5476–5480.
33. Polykratis A, Hermance N, Zelic M, Roderick J, Kim C, Van T-M, Lee TH, Chan FKM, Pasparakis M & Kelliher MA (2014) Cutting edge: RIPK1 kinase inactive mice are viable and protected from TNF-induced necroptosis in vivo. J Immunol 193, 1539–1543.
34. Chen W, Wu J, Li L, Zhang Z, Ren J, Liang Y, Chen F, Yang C, Zhou Z, Sean SuS et al. (2015) Ppm1b negatively regulates necroptosis through dephosphorylating Rip3. Nat Cell Biol 17, 434–444.
35. Li D, Xu T, Cao Y, Wang H, Li L, Chen S, Wang X & Shen Z (2015) A cytosolic heat shock protein 90 and cochaperone CDC37 complex is required for RIP3 activation during necroptosis. Proc Natl Acad Sci USA 112, 5017–5022.
36. Lin Y, Devin A, Rodriguez Y & Liu ZG (1999) Cleavage of the death domain kinase RIP by caspase-8 prompts TNF-induced apoptosis. Genes Dev 13, 2514–2526.
37. Rébé C, Cathelin S, Launay S, Filomenko R, Prévotat L, L'Ollivier C, Gyan E, Micheau O, Grant S, Dubart-Kupperschmitt A et al. (2007) Caspase-8 prevents sustained activation of NF-kappaB in monocytes undergoing macrophagic differentiation. Blood 109, 1442–1450.
38. Feng S, Yang Y, Mei Y, Ma L, Zhu D-E, Hoti N, Castanares M & Wu M (2007) Cleavage of RIP3 inactivates its caspase-independent apoptosis pathway by removal of kinase domain. Cell Signal 19, 2056–2067.
39. Pop C, Oberst A, Drag M, Van Raam BJ, Riedl SJ, Green DR & Salvesen GS (2011) FLIP(L) induces caspase 8 activity in the absence of interdomain caspase 8 cleavage and alters substrate specificity. Biochem J 433, 447–457.
40. Newton K, Dugger DL, Wickliffe KE, Kapoor N, Cristina de-Almagro M, Vucic D, Komuves L, Ferrando RE, French DM, Webster J et al. (2014) Activity of protein kinase RIPK3 determines whether cells die by necroptosis or apoptosis. Science 343, 1357–1360.
41. Mandal P, Berger SB, Pillay S, Moriwaki K, Huang C, Guo H, Lich JD, Finger J, Kasparcova V, Votta B et al. (2014) RIP3 induces apoptosis independent of pronecrotic kinase activity. Mol Cell 56, 481–495.
42. Varfolomeev E, Blankenship JW, Wayson SM, Fedorova AV, Kayagaki N, Garg P, Zobel K, Dynek JN, Elliott LO, Wallweber HJ et al. (2007) IAP antagonists induce autoubiquitination of c-IAPs, NF-κB activation, and TNFα-dependent apoptosis. Cell 131, 669–681.
43. Upton JW, Kaiser WJ & Mocarski ES (2010) Virus inhibition of RIP3-dependent necrosis. Cell Host Microbe 7, 302–313.
44. Upton JW, Kaiser WJ & Mocarski ES (2012) DAI/ZBP1/DLM-1 complexes with RIP3 to mediate virus-induced programmed necrosis that is targeted by murine cytomegalovirus vIRA. Cell Host Microbe 11, 290–297.
45. Guo H, Omoto S, Harris PA, Finger JN, Bertin J, Gough PJ, Kaiser WJ & Mocarski ES (2015) Herpes simplex virus suppresses necroptosis in human cells. Cell Host Microbe 17, 243–251.
46. Huang Z, Wu S-Q, Liang Y, Zhou X, Chen W, Li L, Wu J, Zhuang Q, Chen C, Li J et al. (2015) RIP1/RIP3 binding to HSV-1 ICP6 initiates necroptosis to restrict virus propagation in mice. Cell Host Microbe 17, 229–242.
47. Kaiser WJ, Upton JW & Mocarski ES (2013) Viral modulation of programmed necrosis. Curr Opin Virol 3, 296–306.
48. Li M & Beg AA (2000) Induction of necrotic-like cell death by tumor necrosis factor alpha and caspase inhibitors: novel mechanism for killing virus-infected cells. J Virol 74, 7470–7477.
49. Cho YS, Challa S, Moquin D, Genga R, Ray TD, Guildford M & Chan FK-M (2009) Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell 137, 1112–1123.
50. Duprez L, Takahashi N, Van Hauwermeiren F, Vandendriessche B, Goossens V, Vanden Berghe T, Declercq W, Libert C, Cauwels A & Vandenabeele P (2011) RIP kinase-dependent necrosis drives lethal systemic inflammatory response syndrome. Immunity 35, 908-918.
51. Linkermann A, Bräsen JH, Darding M, Jin MK, Sanz AB, Heller J-O, De Zen F, Weinlich R, Ortiz A, Walczak H et al. (2013) Two independent pathways of regulated necrosis mediate ischemia-reperfusion injury. Proc Natl Acad Sci USA 110, 12024–12029.
52. Luedde M, Lutz M, Carter N, Sosna J, Jacoby C, Vucur M, Gautheron J, Roderburg C, Borg N, Reisinger F et al. (2014) RIP3, a kinase promoting necroptotic cell death, mediates adverse remodelling after myocardial infarction. Cardiovasc Res 103, 206–216.
53. Lin J, Li H, Yang M, Ren J, Huang Z, Han F, Huang J, Ma J, Zhang D, Zhang Z et al. (2013) A role of RIP3-mediated macrophage necrosis in atherosclerosis development. Cell Rep 3, 200–210.
54. Gautheron J, Vucur M, Reisinger F, Vargas Cardenas D, Roderburg C, Koppe C, Kreggenwinkel K, Schneider AT, Bartneck M, Neumann UP et al. (2014) A positive feedback loop between RIP3 and JNK controls non-alcoholic steatohepatitis. EMBO Mol Med 6, 1062–1074.
55. Ofengeim D, Ito Y, Najafov A, Zhang Y, Shan B, DeWitt JP, Ye J, Zhang X, Chang A, Vakifahmetoglu-Norberg H et al. (2015) Activation of necroptosis in multiple sclerosis. Cell Rep 10, 1836–1849.
56. Rodriguez DA, Weinlich R, Brown S, Guy C, Fitzgerald P, Dillon CP, Oberst A, Quarato G, Low J, Cripps JG et al. (2015) Characterization of RIPK3-mediated phosphorylation of the activation loop of MLKL during necroptosis. Cell Death Differ doi: 10.1038/cdd.2015.70. [Epub ahead of print].
57. Roderick JE, Hermance N, Zelic M, Simmons MJ, Polykratis A, Pasparakis M & Kelliher MA (2014) Hematopoietic RIPK1 deficiency results in bone marrow failure caused by apoptosis and RIPK3-mediated necroptosis. Proc Natl Acad Sci USA 111, 14436–14441.
58. de Almagro MC, Goncharov T, Newton K & Vucic D (2015) Cellular IAP proteins and LUBAC differentially regulate necrosome-associated RIP1 ubiquitination. Cell Death Dis 6, e1800.
59. Moriwaki K, Balaji S, McQuade T, Malhotra N, Kang J & Chan FK-M (2014) The necroptosis adaptor RIPK3 promotes injury-induced cytokine expression and tissue repair. Immunity 41, 567–578.
60. Vince JE, Wong WW-L, Gentle I, Lawlor KE, Allam R, O'Reilly L, Mason K, Gross O, Ma S, Guarda G et al. (2012) Inhibitor of apoptosis proteins limit RIP3 kinase-dependent interleukin-1 activation. Immunity 36, 215–227.
61. Lawlor KE, Khan N, Mildenhall A, Gerlic M, Croker BA, D'Cruz AA, Hall C, Kaur Spall S, Anderton H, Masters SL et al. (2015) RIPK3 promotes cell death and NLRP3 inflammasome activation in the absence of MLKL. Nat Commun 6, 6282.
62. Kang S, Fernandes-Alnemri T, Rogers C, Mayes L, Wang Y, Dillon C, Roback L, Kaiser W, Oberst A, Sagara J et al. (2015) Caspase-8 scaffolding function and MLKL regulate NLRP3 inflammasome activation downstream of TLR3. Nat Commun 6, 7515.
63. Kang T-B, Yang S-H, Toth B, Kovalenko A & Wallach D (2012) Caspase-8 blocks kinase RIPK3-mediated activation of the NLRP3 inflammasome. Immunity 38, 27–40.
64. Koo G-B, Morgan MJ, Lee D-G, Kim W-J, Yoon J-H, Koo JS, Kim Il S, Kim SJ, Son MK, Hong SS et al. (2015) Methylation-dependent loss of RIP3 expression in cancer represses programmed necrosis in response to chemotherapeutics. Cell Res 25, 707–725.
65. Mocarski ES, Kaiser WJ, Livingston-Rosanoff D, Upton JW & Daley-Bauer LP (2014) True Grit: programmed necrosis in antiviral host defense, inflammation, and immunogenicity. J Immunol 192, 2019–2026.
66. Gurung P, Anand PK, Malireddi RKS, Vande Walle L, Van Opdenbosch N, Dillon CP, Weinlich R, Green DR, Lamkanfi M & Kanneganti T-D (2014) FADD and caspase-8 mediate priming and activation of the canonical and noncanonical Nlrp3 inflammasomes. J Immunol 192, 1835–1846.